4//SEC Filing
Menzaghi Frederique Ph.D. 4
Accession 0001209191-22-062632
CIK 0001346830other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:54 PM ET
Size
5.2 KB
Accession
0001209191-22-062632
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Sale
Common Stock
2022-12-21$11.27/sh−3,506$39,513→ 166,275 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on December 21, 2021, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001597152
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:54 PM ET
- Size
- 5.2 KB